Company profile

Orasis Pharmaceuticals

Therapeutics (presbyopia)ChallengingFounded 2016

A presbyopia-correcting eye drop (CSF-1 / QDrops), funded through a $126M total.

About

Developing an investigational eye drop to correct near vision in presbyopia — the 'reading glasses in a bottle' category.

HQ: Israel / US

Funding

$126M total across rounds